MedTrace Logo

Do Patient-Centric mHealth Programs Improve Patient Engagement and Health Outcomes.

NCT02757183 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2016-05-13

No results posted yet for this study

Summary

The "INTELLIH" (brand name of the mobile health application) Diabetes Study is to understand the usage of a mobile health application, IntelliH, and connected wireless devices such as glucometer by the diabetic patients and ascertain if there are any improvements in short-term health outcomes.

Conditions

Interventions

DEVICE

"IntelliH"

"IntelliH" is a mobile health and a web-based software application that allows patients to enter their blood glucose, weight, medication, diet and other life-style data for review by their providers and monitor their health remotely.

Sponsors & Collaborators

  • Cedars-Sinai Medical Center

    collaborator OTHER

  • AnalyticsPlus, Inc.

    lead INDUSTRY

Principal Investigators

  • Ruchi Mathur, MD · Cedars-Sinai Medical Center

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2016-11-30
Completion
2017-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02757183 on ClinicalTrials.gov